Loratadine syrup patents are a key factor in the drug's market availability. Understanding these patents can clarify when generic versions might become accessible and the competitive landscape [1].
When does the patent for loratadine syrup expire?
The primary patents for loratadine, including those covering its syrup formulation, have long since expired [2]. The original U.S. patent for loratadine expired in 2007 [3]. Subsequent patents related to specific formulations or manufacturing processes may have had later expiration dates, but the core protection for the molecule has lapsed [2]. This expiration opened the door for the widespread availability of generic loratadine products.
What does patent expiry mean for loratadine syrup?
Patent expiry signifies the end of market exclusivity for the brand-name drug [4]. Once patents expire, other pharmaceutical companies can manufacture and sell generic versions of the drug, provided they meet regulatory approval [5]. This typically leads to a significant decrease in the price of the medication due to increased competition [4]. For loratadine syrup, this means that multiple manufacturers now offer generic formulations, making it more affordable and accessible to consumers [1].
How do loratadine patents affect generic availability?
The expiration of loratadine's patents directly enables the production and sale of generic loratadine syrup [2, 5]. Without these patent protections, there are no legal barriers preventing other companies from producing bioequivalent versions of the drug [5]. Regulatory agencies, such as the U.S. Food and Drug Administration (FDA), then review applications for generic drugs to ensure they are safe, effective, and equivalent to the brand-name product before they can be marketed [5].
Are there any other protections for loratadine?
While the main patents for loratadine have expired, other forms of market exclusivity can exist. These can include data exclusivity, which is granted upon regulatory approval of a new drug application, or secondary patents covering specific manufacturing processes, polymorphs, or dosage forms [2, 4]. However, for loratadine, these secondary protections have not historically prevented the widespread introduction of generic competition following the expiry of the primary molecule patents [3].
Where can I find information on drug patents like loratadine's?
Resources like DrugPatentWatch.com provide detailed information on drug patents, including expiration dates and patent litigation [1]. These databases are valuable for tracking the patent status of medications and understanding the timeline for generic entry.
Sources:
[1] DrugPatentWatch.com
[2] https://drugpatentwatch.com/
[3] https://www.fda.gov/
[4] https://www.pharmaceutical-technology.com/
[5] https://www.ncbi.nlm.nih.gov/